Skip to main content
Top

Pathology & Oncology Research

Issue 3/2002

Content (10 Articles)

Article

Expression of CD44s in human colorectal cancer

Mousa Khoursheed, T. C. Mathew, R. R. Makar, L. Sonia, H. Abul, S. Asfar, H. Al-Sayer, H. M. Dashti, A. Al-Bader

Article

Clinicopathologic evaluation of CDw75 antigen expression in colorectal adenocarcinomas

Gülsüm Özlem Elpek, Tekinalp Gelen, Gülten Karpuzoglu, Tuncer Karpuzoglu, Nazif Hikmet Aksoy, Nuran Keles

Article

Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III–IV malignant melanoma

Teodóra Bánfalvi, Mariann Boldizsár, Maria Gergye, Katalin Gilde, Tibor Kremmer, Szabolcs Ottó

Article

Prevalence of mycosis fungoides and its association with EBV and HTLV-1 in Pakistanian patients

Samina Noorali, Nausheen Yaqoob, Muhammad Israr Nasir, Tariq Moatter, Shahid Pervez

Case Report

Primary neuroendocrine carcinoma of the mediastinum

Füruzan Kacar, Ibrahim Meteoglu, Serdar Sen, Edi Levi

Case Report

Combined occurrence of prostate carcinoma and malacoplakia

Dénes L. Répássy, András Iványi, Sándor Csata, György Tamás

Seminar

Molecular pathology of tumor metastasis

József Tímár, Orsolya Csuka, Zsolt Orosz, Andres Jeney, László Kopper

In Memoriam

Outstanding cancerologist Leon M Shabad and his scientific activity (100th anniversary)

Laima Griciute, Saule Uleckiene, Janina Didziapetriene

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine